Identifying Healthcare-associated Infections

Identifying Healthcare-associated Infections (HAI) for NHSN Surveillance

To standardize the classification of an infection as present on admission (POA) or a

healthcare-associated infection (HAI), the following objective surveillance definitions and
guidance are used for NHSN surveillance:

• 7-day Infection Window Period (IWP)

• Date of Event (DOE)
• POA
• HAI
• 14-day Repeat Infection Timeframe (RIT)
• Secondary BSI Attribution Period (SBAP)
• Pathogen Assignment Guidance
• Location of Attribution (LOA)
• Transfer Rule

The intention of this approach is to align criteria and definitions and decrease subjectivity
while maintaining epidemiologic standardization and clinical relevance. A variety of
scenarios to include repeat infections of the same type, concurrent infections of differing
types, and pathogen assignment in multi-pathogen infections are addressed. See Appendix
Flow Diagram for NHSN Event Determination.

General Instructions

1. The guidance found in this Chapter is not applicable when performing SSI, VAE,
PedVAE or LabID surveillance. Infection window period, Date of Event, POA, HAI,
and RIT, SBAP definitions as defined in this chapter do not apply to SSI, VAE,
PedVAE, or LabID Events (Table 1).
Please refer to Chapters 9, 10, 11 and 12 respectively for guidance specific to these
event determinations

2. Organisms belonging to the following genera are typically causes of community-

associated infections and are rarely or are not known to be causes of healthcare-
associated infections. They are excluded, and cannot be used to meet any NHSN
definition: Blastomyces, Histoplasma, Coccidioides, Paracoccidioides, Cryptococcus
and Pneumocystis. Additionally refer to individual event protocols for pathogen
exclusions specific to the event being reported for example, BSI, UTI, PNEU, ENDO,
GIT, IAB.

2-1
January 2019
 Identifying Healthcare-associated Infections

3. If the date of specimen collection is on or after the date of documentation of evidence

of consent AND the patient is being supported for organ donation purposes, an event
identified using the specimen culture result or microbiologic non-culture based
diagnostic test result should not be reported as an HAI. The patient should, however,
still be included in device and patient day denominator data collection.

4. Hospice, palliative or comfort care patients are not excluded from NHSN
surveillance.

5. Identification of organisms from specimens collected during post-mortem

examination (autopsy) are only eligible for use in meeting the CNS/IC (Intracranial)
infection definition and the PNEU infection definition using lung tissue specimen
obtained by transthoracic or transbronchial biopsy immediately post-mortem. For all
other NHSN definitions autopsy specimens/reports are not eligible for use.

6. Infections occurring in newborns with date of event on hospital day 1 or day 2 are
considered POA. Those with date of event on day 3 or later are HAI. This includes
infections acquired transplacentally (for example but not limited to herpes simplex,
toxoplasmosis, rubella, cytomegalovirus, or syphilis) or as a result from passage
through the birth canal. Exception: See guidance about non-reporting of CLABSIs
with Group B Streptococcus during a neonate’s first 6 days of life found in the
Comments and Reporting Instructions section of the Bloodstream Infection Event
(Central Line-Associated Bloodstream Infection and Non-central line-associated
Bloodstream Infection) protocol.

7. Reactivation of a latent infection (for example but not limited to herpes, shingles,
syphilis, or tuberculosis) is not considered to be an HAI.

Table 1: Exceptions to application of Chapter 2

- SSI* LabID* VAE* PedVAE*
Infection Window Period †

Date of Event
Applicable
Applicable

Applicable
Applicable

POA
Not

Not

Not

Not

HAI
Repeat Infection Timeframe (RIT)†
Secondary BSI Attribution Period†
,†
See ENDO criteria in Chapter 17: CDC/NHSN Surveillance Definitions for Specific Types of
Infections for endocarditis
*See SSI, LabID,VAE, and PedVAE surveillance protocols

2-2
January 2019
 Identifying Healthcare-associated Infections

Observation Patients in Inpatient Locations:

For purposes of NHSN surveillance, if an observation patient is admitted to an inpatient
location, the patient must be included in all surveillance events designated in the monthly
reporting plan and included in patient and device day counts. The patient is being housed,
monitored, and cared for in an inpatient location and therefore is at risk for acquisition of an
HAI.

Infection Window Period:

The Infection Window Period (IWP) is defined as the 7-days during which all site-specific
infection criteria must be met. It includes the collection date of the first positive diagnostic
test that is used as an element to meet the site-specific infection criterion, the 3 calendar
days before and the 3 calendar days after (Table 2). For purposes of defining the Infection
Window Period the following examples are considered diagnostic tests:

• laboratory specimen collection

• imaging test
• procedure or exam

Table 2: Infection Window Period

3 days
Infection Window Period

before
Date of first positive diagnostic test that is used as an
element of the site-specific criterion
OR
In the absence of a diagnostic test, use the date of the
first documented localized sign or symptom that is used
as an element of the site-specific criterion
3 days
after

2-3
January 2019
 Identifying Healthcare-associated Infections

It is important to use the first diagnostic test that creates an infection window period
during which all elements of the criterion can be found. See example below.

Example
When meeting PNEU definition using the PNU2 criterion, identification of an eligible
organism from blood or from a site-specific specimen, and an imaging test may be available.
Both the organism identification and the imaging test are diagnostic tests. Use the first
diagnostic test for which all elements of the PNU2 criterion occur within the infection
window period.

In this example below, Option 1 uses the imaging test (not the blood culture) to set the
infection window period. This is the first diagnostic test that creates an infection window
period in which all elements of PNU2 criterion occur.

Option 1: Correct diagnostic test Option 2: Incorrect diagnostic test

selection selection

Hospital Infection Window Hospital Infection Window

Day Period Day Period
-2 -2
-1 -1
1 1
2 POA New onset cough 2 New onset cough
3 Imaging test: Infiltrate 3 HAI Imaging test: Infiltrate
4 Fever > 38.0 C
4 Fever > 38.0 C
5 Fever > 38.0 C
5 Fever > 38.0 C
6 Blood culture: A. baumannii
6 Blood culture: A. baumannii
7 Rales, Fever > 38.0 C
7 Rales, Fever > 38.0 C
8 Cough, Rales
8 Cough, Rales
9
9
10 10
11
11
12
13 12
14 13
15 14
16 15
17 16
17

2-4
January 2019
 Identifying Healthcare-associated Infections

Infection Window Period Special Considerations

1. Infection criteria that do not include a diagnostic test:

For site-specific infection criteria that do not include a diagnostic test, the date of
the first documented localized sign or symptom that is used as an element of the site-
specific infection criterion is used to define the infection window period for example,
diarrhea, site-specific pain, purulent drainage. Note that a non-specific sign or
symptom for example, fever is not considered to be localized and therefore is not to
be used to define the infection window period.

For example, when meeting EMET using criterion 2, there is no diagnostic test as a
part of this criterion. The date of the first documented localized sign or symptom,
purulent drainage or pain or tenderness that is used as an element to meet EMET
criterion 2 is to be used to set the infection window period. Fever is not a localized
sign.

2. More than one criterion can be met:

When more than one criterion of a site-specific infection definition is met,

identify the infection window period that results in the earliest date of event.

Example
A patient has purulent drainage noted at a superficial wound site on hospital day 2. It
is documented on day 3 that the wound site is painful and swelling is present. S.
aureus is identified from a wound specimen with collection date on day 4. SKIN
definition can be met using criterion 2a with pain, swelling and positive culture from
the site-specific specimen (diagnostic test) and also met using criterion 1 with
purulent drainage (sign). Using the sign of infection, purulent drainage, to set the
infection window period results in Criterion 1 being met and provides the earliest date
of event.

2-5
January 2019
 Identifying Healthcare-associated Infections

SKIN Criterion 1 SKIN Criterion 2a

Correct Determination
Hospital Infection Window
Day Period Hospital Infection Window
Day Period
-2
-2
-1
-1
1
1
2 POA Purulent Drainage from
2
wound
(SKIN Criterion 1) 3 HAI Pain, Swelling
(SKIN Criterion 2a)
3
4 Drainage culture: S.
4 aureus
5 5
6 6
7 7
8 8
9 9
10 10
11 11
12 12
13 13
14 14
15 15
16 16
17 17

3. Endocarditis:

When meeting the Endocarditis (ENDO) definition, the Infection Window Period
(IWP) is defined as the 21 days during which all site-specific infection criteria
must be met. It includes the date the first positive diagnostic test that is used as an
element of the ENDO infection criterion was obtained, the 10 calendars days
before and the 10 calendar days after. The IWP is lengthened for ENDO to
accommodate the extended diagnostic timeframe that is frequently required to
reach a clinical determination of endocarditis.

2-6
January 2019
 Identifying Healthcare-associated Infections

Date of Event (Event Date):

The Date of Event (DOE) is the date the first element used to meet an NHSN site-specific
infection criterion occurs for the first time within the seven-day infection window period
(Table 3 and Table 4).

An infection is considered Present on Admission (POA) if the date of event of the

NHSN site-specific infection criterion occurs during the POA time period, which is
defined as the day of admission to an inpatient location (calendar day 1), the 2 days
before admission, and the calendar day after admission. For purposes of NHSN
surveillance and determination of the Repeat Infection Timeframe (as defined below)
if the date of event is determined to be either of the two days prior to inpatient
admission, then the date of event will be hospital day 1.

An infection is considered a Healthcare-associated Infection (HAI) if the date of

event of the NHSN site-specific infection criterion occurs on or after the 3rd calendar
day of admission to an inpatient location where day of admission is calendar day 1.

Note:
Accurate determination of DOE is critical because DOE is used to determine:
• if an event is HAI or POA
• location of attribution
• device association
• day 1 of the Repeat Infection Timeframe

Table 3: Date of Event and Classification Determination

Hospital Day Date of Event Classification

Assignment for RIT
2 days before admit Hospital Day 1
1 day before admit Hospital Day 1
POA
1 Hospital Day 1
2 Hospital Day 2
3 Hospital Day 3
4 Hospital Day 4 HAI
5 Hospital Day 5

2-7
January 2019
 Identifying Healthcare-associated Infections

Table 4: Infection Window Period and Date of Event

(Patient age < 65)

Note the date of event is the date the first element used to meet the site-specific infection
criterion occurs for the first time in the infection window period. In the first example, it is
day 2, the date the fever occurs for the first time in the infection window period and this
results in a POA determination. In the second example it is day 4, the date of the diagnostic
test, which is the first element in the infection window period and this results in an HAI
determination. Date of event may be, but is not always, the date of the diagnostic test which
is used to set the infection window period.

Example 1 Example 2
HOSPITAL INFECTION HOSPITAL INFECTION
DAY WINDOW PERIOD DAY WINDOW PERIOD
1 1
2 Date of Event Fever > 38.0 C 2
3 3
4 Urine culture: 4 Date of Event Urine culture:
>100,000 CFU/ ml >100,000 CFU/ml
E. coli E. coli
5 5 Fever > 38.0 C
6 6 Fever > 38.0 C
7 7
8 8
9 9
10 10
11 11
12 12
13 13
14 14
15 15
16 16
17 17
18 18
SUTI-POA SUTI-HAI
Date of Event = 2 Date of Event = 4
Pathogen = E. coli Pathogen = E. coli

2-8
January 2019
 Identifying Healthcare-associated Infections

Notes:
• Acceptable documentation includes patient-reported signs or symptoms within the POA
timeframe, documented in the medical record by a healthcare professional. Information
communicated verbally from facility to facility, or information found in another facility’s
medical record cannot be used unless also documented in the current facility’s medical
record (with the exception of post –discharge SSI surveillance.) For example, the
following would be eligible for use if documented in the current facility’s medical record:
o patients states measured fever > 38.0° C or >100.4° F occurring in the POA
timeframe
o nursing home reports fever prior to arrival to the hospital and occurring in the
POA timeframe
o patient complains of dysuria
o copy of laboratory test result from another facility

• Physician diagnosis can be accepted as evidence of an infection only when physician

diagnosis is an element of the specific infection definition. For example, physician
diagnosis is not an element of any UTI criteria; therefore, physician diagnosis of a UTI
may not be used to satisfy POA status of a UTI.

Repeat Infection Timeframe:

The Repeat Infection Timeframe (RIT) is a 14-day timeframe during which no new
infections of the same type are reported.

• The RIT applies to both POA and HAI determinations.

• The date of event is Day 1 of the 14-day RIT.
• If criteria for the same type of infection are met and the date of event is within the
14-day RIT, a new event is not identified or reported.
• Additional pathogens recovered during the RIT from the same type of infection are
added to the event.
• Note the original date of event is maintained as is the original 14-day RIT.
• Device association determination and location of attribution are not to be amended.
See examples in Table 5 and Table 6 below.

2-9
January 2019
 Identifying Healthcare-associated Infections

• The RIT will apply at the level of specific type of infection with the exception of BSI,
UTI, and PNEU where the RIT will apply at the major type of infection.

Specific Type Example:

Patients will have no more than one SKIN infection reported in a SKIN RIT,
but may have overlapping or simultaneous SKIN RIT and DECU RIT

Major Type Examples:

• Patients will have no more than one BSI reported in a BSI RIT (LCBI
1, LCBI 2, MBI-LCBI 1,MBI-LCBI 2, MBI-LCBI 3)
• Patients will have no more than one PNEU reported in a PNEU RIT
(PNU1, PNU2, PNU3).
• Patients will have no more than one UTI reported in a UTI RIT
(SUTI, ABUTI, USI)

• The RIT applies during a patient’s single admission, including the day of discharge
and the day after, in keeping with the Transfer Rule. An RIT does not carry over
from one admission to another even if readmission is to the same facility.

• The RIT for Endocarditis (ENDO) is extended to include the remainder of the
patient’s current admission.

2-10
January 2019
 Identifying Healthcare-associated Infections

In the example below (Table 5), the Date of Event is hospital day 4. The 14-day RIT is
hospital day 4 through day 17. On hospital day 12, within the RIT, a urine culture with >
100,000 CFU/ml S. aureus is identified. The urine pathogen identified from the hospital day
12 culture is added to the originally identified infection on hospital day 4. Determination of
a new infection or continuation of ongoing infection is not required. The original date of
event and the RIT are maintained.

Table 5: Repeat Infection Timeframe

2-11
January 2019
 Identifying Healthcare-associated Infections

In the example below (Table 6) a non-catheter associated UTI is identified with date of event
on day 4. This sets an RIT day 4 -17. On day 5 a Foley catheter is inserted. On day 8, within
the RIT, a urine culture with > 100,000 CFU/ml E.coli is identified. The E.coli is added to
the originally identified day 4 event. The device association does not change and the date of
event and RIT are maintained.

Table 6. Repeat Infection Timeframe and Interim Device Insertion

Notes:
• A patient may have negative cultures during the RIT without impact on the RIT.
• Do not change the device-association determination during the RIT.
• Do not change location of attribution determination during the RIT.

2-12
January 2019
 Identifying Healthcare-associated Infections

Secondary BSI Attribution Period

(Refer to Appendix B, Secondary Bloodstream Infection (BSI) Guide of the BSI Event
Protocol)
The Secondary BSI Attribution Period*(SBAP) is the period in which a blood specimen must
be collected for a secondary bloodstream infection to be attributed to a primary site infection.
This period includes the Infection Window Period combined with the Repeat Infection
Timeframe (RIT). It is 14-17 days in length depending upon the date of event.

For purposes of NHSN, in order for a bloodstream infection to be determined

secondary to another site of infection the following requirements must be met: ‡

An NHSN site-specific definition must be met; either one of the CDC/NHSN Surveillance
Definitions for Specific Types of Infections (defined in Chapter 17), or UTI, PNEU or SSI
definition.

AND

One of the following scenarios must be met:

Scenario 1: At least one organism from the blood specimen matches an organism
identified from the site-specific infection that is used as an element to meet the NHSN
site-specific infection criterion and the blood specimen is collected in the secondary
BSI attribution period.(infection window period + repeat infection timeframe).

OR

Scenario 2: An organism identified in the blood specimen is an element that is used

to meet the NHSN site-specific infection criterion, and therefore is collected during
the site-specific infection window period.

*Notes:

• When meeting the Endocarditis (ENDO) definition, the secondary BSI attribution
period includes the 21-day infection window period and all subsequent days of the
patient’s current admission.

o As a result of this lengthy ENDO secondary BSI attribution period, secondary

BSI pathogen assignment for ENDO, is limited to organism(s) identified in
blood specimen that match the organism(s) used to meet the ENDO definition.
For example, if the ENDO definition was met using a site-specific specimen
(cardiac vegetation) or using a blood specimen where S. aureus was the

2-13
January 2019
 Identifying Healthcare-associated Infections

identified organism and subsequently a blood specimen collected during the

ENDO secondary BSI attribution period is positive for S. aureus and E.coli,
while the S. aureus can be assigned to the ENDO event, it cannot be assumed
the E.coli can be assigned as a secondary BSI pathogen. The blood organism
(E.coli) does not match the organism (S. aureus) used to meet the ENDO
definition. If the blood specimen can be used to meet an ENDO definition
criterion both organisms can be assigned. Otherwise the E.coli will need to be
investigated as a separate BSI and be identified as a secondary BSI to another
site-specific infection or determined to be a primary BSI.
‡
Exception:
Necrotizing enterocolitis (NEC) criteria include neither a site-specific specimen nor organism
identified from blood specimen, however an exception for assigning a BSI secondary to NEC
is provided.

A BSI is considered secondary to NEC if the patient meets one of the two NEC
criteria AND an organism identified from blood specimen collected during the
secondary BSI attribution period is an LCBI pathogen, or the same common
commensal which is identified from two or more blood specimens drawn on separate
occasions collected on the same or consecutive days.

2-14
January 2019
 Identifying Healthcare-associated Infections

Secondary BSI Attribution Period Tables:

In the example below (Table 7), the Date of Event is hospital day 4. The 14-day RIT is
hospital day 4 through day 17. The Secondary BSI Attribution Period is the Infection
Window Period combined with the Repeat Infection Timeframe (RIT), 17 days in this
example. The blood culture collected on hospital day 10 has a matching pathogen to the site-
specific culture used to meet SUTI definition, and therefore, a secondary BSI is identified.

Table 7: Secondary BSI Attribution Period

2-15
January 2019
 Identifying Healthcare-associated Infections

In the example below (Table 8), the Date of Event is hospital day 4. The 14-day RIT is
hospital day 4 through day 17. The secondary BSI Attribution Period is 17 days in length.
The blood culture collected on hospital day 5 is used as an element to meet the PNU2
infection definition and therefore a secondary BSI is identified.

Table 8: Secondary BSI Attribution Period

2-16
January 2019
 Identifying Healthcare-associated Infections

Pathogen Assignment Guidance:

The following provides guidance for reporting pathogens associated with site-specific
infections that are identified during the RIT or during the secondary BSI attribution period.

• Additional eligible pathogens recovered during the RIT from the same type of infection
are added to the event.
• Report all site-specific pathogens before secondary BSI pathogens.
o SUTIs can only have two organisms entered according to NHSN application
rules. However, if yes is selected for the secondary BSI field, the third pathogen
field will become available for data entry.
• If at least one BSI pathogen with a collection date in the secondary BSI attribution period
matches organism from a specimen (either a site-specific specimen or a blood specimen)
that was used to meet a site-specific infection criterion additional eligible BSI pathogens
are also considered secondary to the event.
• BSI pathogens may be assigned to more than one infection source at the same time in the
following scenarios.
1) Secondary BSI pathogen assigned to two different site-specific infections (see
Example 1)
OR
2) Secondary BSI pathogen assigned to a site-specific infection and assigned as
pathogen to a primary BSI event (see Example 2).
Example 1:

K. pneumoniae is identified in a blood culture during the RIT of a SUTI with K.

pneumoniae. The patient is also recovering from COLO surgery performed at your
facility in the past week and now has:
o Fever > 38.0° C,
o Abdominal pain, and
o CT showing abdominal abscess
These three elements, when combined with a positive blood culture, meet IAB criterion
3b. If a facility includes both UTI and SSI (for COLO) in their monthly reporting
plan, a UTI and SSI will be reported, both with a secondary BSI and with pathogen
K. pneumoniae.

Note: As per the SSI protocol, the SSI-IAB does not have an Infection Window Period or
RIT. The secondary BSI attribution period is 17 days in duration including the date of
event, 3 days prior and 13 days after the date of event.

2-17
January 2019
 Identifying Healthcare-associated Infections

Cont. Example 1

2-18
January 2019
 Identifying Healthcare-associated Infections

Example 2:
On day 4 of hospital admission, S. aureus is identified in a blood culture
meeting the HAI, LCBI 1 criterion. On day 8 the patient has a fever > 38.0° C
and E. coli is identified in a urine culture meeting the SUTI definition. On
hospital day 13, a blood culture positive for E.coli is identified. Because the
blood culture occurs within both the LCBI RIT and the SUTI secondary
BSI attribution period, the pathogen, E.coli is assigned to both events.

• Pathogens excluded from specific infection definitions (for example. yeast in UTI, or
Enterococcus spp. in PNEU) are also excluded as pathogens for BSIs secondary to that
type of infection (specifically they cannot be added to one of these infections as a
pathogen). The excluded organism must be accounted for as either:
1) A primary bloodstream infection (BSI/CLABSI) (see Example 3)
OR

2) A secondary BSI attributed to another primary infection (for example, to an IAB

or SINU), in accordance with Appendix B, Secondary BSI Guide of the BSI
Event protocol (see Example 4)

2-19
January 2019
 Identifying Healthcare-associated Infections

Example 3:
A SUTI with Enterococcus faecalis is identified and a subsequent blood culture
with yeast and E. faecalis is collected during the SUTI secondary BSI attribution
period. A BSI secondary to SUTI is identified. E. faecalis is already
documented as a pathogen, but the yeast will not be reported as a secondary
BSI pathogen, because yeasts are excluded as organisms in the UTI
definition. In this example, no other primary source of infection for which the
yeast BSI can be assigned as secondary is identified. Therefore a primary BSI
with yeast only is identified.

Note: The Enterococcus faecalis is not assigned as a pathogen for the primary
BSI because if an excluded organism had not been identified, a primary BSI
would not have been reported.

2-20
January 2019
 Identifying Healthcare-associated Infections

Example 4:
A PNU2 with Acinetobacter baumannii cultured from blood is identified.
Note: the positive chest imaging result is the diagnostic test that is used to
define the infection window period. A subsequent blood culture with
Enterococcus faecalis and A. baumannii is collected during the secondary BSI
attribution period of this PNU2 event. Enterococcus faecalis will not be
reported as a pathogen for the PNU2, because Enterococcus spp. are
excluded as organisms in the PNEU definition. Another primary source of
infection, SUTI, is found and Enterococcus faecalis is assigned as a secondary
BSI pathogen.

2-21
January 2019
 Identifying Healthcare-associated Infections

• Determination of a secondary BSI to a primary site of infection does not set an RIT for
all subsequent BSIs. If a blood culture occurs during a site specific infection’s secondary
BSI attribution period and it cannot be used as an element to meet the infection definition
or does not have at least one matching pathogen to the site-specific infection culture used
to meet the site-specific infection criterion the BSI must be evaluated as a new BSI event
(see Example 5)
Example 5:
A SUTI with Enterococcus faecalis is identified and a blood culture with E.
faecalis collected on hospital day 11 within the SUTI secondary BSI
attribution period is also identified. On hospital day 15 (also within the SUTI
RIT and secondary BSI attribution period), a blood culture growing
Staphylococcus aureus is identified. Because the blood growing S. aureus
does not have at least one pathogen that matches the urine culture used to
meet the SUTI criterion the BSI cannot be attributed as secondary to the
SUTI. The BSI will need to be investigated as a new BSI event and either
assigned as a secondary BSI to another primary site of infection or determined
to be a primary BSI.

Note: The secondary BSI attribution period for a primary site of infection does
not establish a repeat infection timeframe for all subsequent BSIs.

2-22
January 2019
 Identifying Healthcare-associated Infections

• When identifying a BSI which appears to fall within a BSI-RIT, it is important to verify
the initial BSI was indeed a primary BSI and not a secondary BSI to site-specific event.
Only primary BSIs create a BSI RIT, therefore, incorrectly establishing a BSI-RIT for a
secondary BSI event can result in the inaccurate assignment of a BSI pathogen(s) and the
identification of a true CLABSI event will likely be missed (see Example 6).

Example 6:

Initially a BSI was identified as POA and therefore not further investigated. Upon
identification of a subsequent BSI it cannot be assumed that the POA BSI set a BSI
RIT. Instead, it must be verified that the initial BSI was indeed a primary BSI and
not a secondary BSI to a site-specific infection. In the example below, upon further
review the initial BSI was actually determined to be a secondary BSI to a SKIN
infection. The SKIN Secondary BSI Attribution Period does not capture all
subsequent BSIs. In this example it can only account for BSIs that have at least one
matching pathogen to the site-specific specimen (wound drainage) used to meet
SKIN. The BSI on hospital day 9 does not match and it also was determined not to be
secondary to another site-specific infection and therefore a CLABSI is identified.

2-23
January 2019
 Identifying Healthcare-associated Infections

Location of Attribution (LOA):

The inpatient location where the patient was assigned on the date of event is the location of
attribution (see Date of Event definition). Non-bedded patient locations, (for example,
Operating Room (OR) or Interventional Radiology (IR)) are not eligible for assignment of
location of attribution for HAI events. Location of attribution must be assigned to a location
where denominator data (for example, patient days, device days) can be collected.

Exception to Location of Attribution:

Transfer Rule: If the date of event is on the date of transfer or discharge, or the next day, the
infection is attributed to the transferring/discharging location. This is called the Transfer
Rule. If the patient was in multiple locations within the transfer rule time frame, attribute the
infection to the first location in which the patient was housed the day before the infection’s
date of event. Receiving locations or facilities should share information about such HAIs
with the transferring location or facility to enable accurate reporting. See examples below.

2-24
January 2019
 Identifying Healthcare-associated Infections

Note: Surveillance after the patient is discharged from the facility is not required. However, if
discovered, any infection with a date of event (DOE) on the day of discharge or the next day is
attributable to the discharging location and should be included in any data reported to NHSN for
that location. No additional device days are reported.

Location Example:

Date Patient Location of

Location Attribution
3/22 Unit A --
3/23 Unit A --
Unit B
3/24 Unit B Unit A
Date of Event
3/25 Unit B --

Facility Example:

Date Patient Location of

Location Attribution
3/22 Facility 1 ---
3/23 Facility 1 ---
Facility 2
3/24 Facility 2 Facility 1
Date of Event
3/25 Facility 2 ---

Multiple transfers within the same facility during the same admission Example:
In instances where a patient has been transferred to more than one location on the
date of an infection, or the day before, attribute the infection to the first location in
which the patient was housed the day before the infection’s date of event.

Date Patient Location of

Location Attribution
3/22 Unit A -
3/23 Unit A -
Unit B
Unit C
3/24 Unit C Unit A
Date of Event Unit D
3/25 Unit D -

2-25
January 2019
 Identifying Healthcare-associated Infections

Note: The complete set of CDC/NHSN HAI site-specific infection criteria, and the
comments and reporting instructions integral to the correct application of the criteria, can be
found in Chapter 17, CDC/NHSN Surveillance Definitions for Specific Types of Infections,
PNEU (Chapter 6), and UTI (Chapter 7).

2-26
January 2019
 Identify the diagnostic test,
APPENDIX: Flow Diagram for NHSN Event Determination
or in the absence of a diagnostic test,
the localized sign/symptom that will
determine the Infection Window
Period (IWP)

Using the patient’s

age and IUC status
decide which
Do all elements
elements of the UTI
required to meet
definition are
Is the diagnostic test the NHSN definition
eligible for use. Do
No Yes a positive urine No occur within the No
all elements
culture? Infection Window
required to meet
Period (IWP)?
the NHSN definition
occur within the
Infection Window
Period (IWP)?

Determine
the Date of Event
STOP (DOE) STOP
Yes Yes
Not an NHSN event Not an NHSN event

Is there a Is there a
UTI Repeat No Repeat
Infection No Infection Yes
Timeframe Is the DOE during Timeframe
(RIT) in place? the Healthcare- (RIT) in place
Determine if the for the same
associated Infection
infection is device- HAI POA event type?
(HAI) or Present on
associated
Admission (POA)
timeframe?
Yes
STOP
No new event is
found, add eligible
pathogens to the
STOP Determine the Determine the 14- original event
No new event is location of day Repeat Infection
found, add eligible attribution Timeframe (RIT)
pathogens to the
original UTI
If not a primary
bloodstream
infection (BSI),
determine the
Refer to the NHSN Patient Safety Component Manual, Secondary BSI
Chapter 2 for detailed guidance. Attribution Period
(SBAP)